Navigation Links
Onyx Pharmaceuticals to Present at Bank of America Health Care Conference
Date:5/8/2008

EMERYVILLE, Calif., May 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Bank of America Health Care Conference on Thursday, May 15, at 11:50 a.m. Pacific Time. Interested parties may access a live webcast of the presentation on our website at: http://www.onyx-pharm.com/wt/page/event_calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through June 15, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer, and other cancers. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)....,Nov.23/PRNewswire/--PearlTherapeuticsInc.,abioph...rthetreatmentofchronicrespiratorydiseases,todayann...dofDirectors.Mr.Rosenhas25yearsofexperienceintheph...yrolesatGileadSciencesandALZACorporation.Hisappoin...six. ,, "Howiebringsawealthofproductdevelopment...
(Date:11/20/2009)... , , , , , , , ...: , A team of scientists from Washington Univ...ld Spring Harbor Laboratory and Iowa State Univers.... , , Click here for more informa... , , , , , , , ...
(Date:11/20/2009).... 20 Veridiam (www.veridiam.com) w...ompany category at the 2009 Workplace Excellence A...ociety for Human Resources Management and recogniz...ices. ,, Veridiam was one of nine winners, sele...es, honored at the recent awards ceremony. San Die...
(Date:11/20/2009)...d., Nov. 20 Novavax, Inc...ced an underwritten public offering of 6,800,000 s... of $3.30 per share. The approximately $21 millio...g discounts and commissions, will be used for prec...ed vaccines, internal research and development pro...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2
...from MedImmune Inc., Elliott Sigal, M.D., Ph.D, fr..., Ph.D from the FDA, and Mark Ratne...IBC Life Sciences announced,the keynote line up fo...Innovative Therapeutics World Congress, to take pl...esentations will include speakers David M. Mott,fr...
...d Wednesday, May 7, 2008 at 10:00 AM EDT, CEDAR K...Nasdaq: EMIS ) today announced its financial resu...Emisphere will host a conference call to discuss f...y 7, 2008. A live Webcast of the conference,call c... http://www.emisphere.com .,The live conference ca...
..., Inc., a rapidly,growing medical device company d...surgical adhesives, announced today that it has cl...illion. The proceeds of this,transaction will supp...al,trials for its lead product, TissuGlu(R), a str...clinical development of Cohera,s product pipeline....
Other Biology Technology:Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress 2Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 2Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 3Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 4Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 5Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 6Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 7Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million 2
(Date:11/23/2009)... is available in German . , Of all global c... in the atmosphere where it contributes to global ...d terrestrial ecosystems such as forests, grasslan... of aquatic and terrestrial ecosystems is consider...reducing climate change. However, new greenhouse g...
(Date:11/22/2009)...herited gene deletion can increase the likelihood ...splantation, an international team of researchers ... Nature Genetics . When the gene, called UGT2B17,... the recipient,s, transplants have a significantly...aft-versus-host disease, in which immune cells fro...
(Date:11/21/2009)...rmany, November 20,2009 / b3c newswire / - KINAX...f a financing round, gaining two new investors in ...e time KINAXO reports that Jrgen Schumacher has be...y board. , KINAXO shareholders Axel Ullrich, Hel...nys institutional investors Mountain Partners, Bio...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 1Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 3American Chemical Societys Weekly PressPac June 3 2009 8740 1American Chemical Societys Weekly PressPac June 3 2009 8740 2American Chemical Societys Weekly PressPac June 3 2009 8740 3American Chemical Societys Weekly PressPac June 3 2009 8740 4American Chemical Societys Weekly PressPac June 3 2009 8740 5American Chemical Societys Weekly PressPac June 3 2009 8740 6American Chemical Societys Weekly PressPac June 3 2009 8740 7American Chemical Societys Weekly PressPac June 3 2009 8740 8American Chemical Societys Weekly PressPac June 3 2009 8740 9American Chemical Societys Weekly PressPac June 3 2009 8740 10Successful Disease Management Programs Can Play Role in Health Care Reform 48168 1Successful Disease Management Programs Can Play Role in Health Care Reform 48168 2Successful Disease Management Programs Can Play Role in Health Care Reform 48168 3Successful Disease Management Programs Can Play Role in Health Care Reform 48168 4Successful Disease Management Programs Can Play Role in Health Care Reform 48168 5Successful Disease Management Programs Can Play Role in Health Care Reform 48168 6
... Cincinnati (UC) scientists say that a recent scie...ant near Cincinnati has identified a second, poten...or former workers. , That sourcesix silos filled ... relatively high levels of radon exposure to 12 pe... of the workers were exposed to low levels of rado...
...ul antioxidant in green tea may prevent or delay t...orgia researchers say. , Researchers were testing...aboratory mouse with type 1 diabetes and primary S...g glands, causing dry mouth and eyes. , "Our stu... EGCG also can prevent and delay insulin-dependent...
...York, NY) The Parkinson,s Disease Foundation (PDF)...d investigations studying the potential of individ...ease (PD). , The grant will support the research ...M.D., Ph.D., both of the University of Wisconsin, ...ission to fund scientific research that has great ...
Other Biology News:Major source of radon exposure overlooked at former Ohio uranium-processing plant 2Major source of radon exposure overlooked at former Ohio uranium-processing plant 3Major source of radon exposure overlooked at former Ohio uranium-processing plant 4Green tea may delay onset of type 1 diabetes 2Green tea may delay onset of type 1 diabetes 3Parkinson's Disease Foundation announces award of $150,000 2
...he GenElute™ Minus EtBr Spin Columns provide... bromide (EtBr)-free DNA (100 bp to 10 kb) from s...The DNA band is excised from an agarose gel and lo...e of the column are a series of membranes and filt...
...he kit provides a simple and efficient method for ... from PCR mixes. DNA fragments selectively absorbe...el extraction or at room temperature for PCR produ... of DNA can be purified with a single prep using Y...
Uniblot accessories from Sigma-Aldrich
Uniblot accessories from Sigma-Aldrich
Biology Products: